Analysis of Examination Results of Ast (Aspartate Aminotransferase) and Alt (Alanine Aminotransferase) Levels in Covid-19 Patient in RS TK II Pelamonia Makassar by Favian Orvala Ruhban, Andi et al.




Urban Health. Vol.3 No. 1 (2021) 
Analysis of Examination Results of Ast (Aspartate Aminotransferase) and Alt 
(Alanine Aminotransferase) Levels in Covid-19 Patient in 
RS TK II Pelamonia Makassar 
 
Andi Favian Orvala Ruhban1*,Syahida Djasang2, Rahman3 
1,2,3 Medical Laboratory Technology Departement Health Polytechnic of Makassar 
*Email : andifavian1999@gmail.com/085340896464 
 
ABSTRACT 
Covid-19 (Corona Virus Disease 2019) patients tend to have abnormalities in liver function tests, therefore the examination of 
AST and ALT levels as very specific parameters, is really useful in assessing liver function and exploring the severity of the 
disease suffered by patients. The aims of this study was to analyze the examination results of AST (Aspartate Aminotransferase) 
and ALT (Alanine Aminotransferase) levels in COVID-19 patient. The type of research wais in the form of laboratory 
observation by referring to secondary data obtained from the medical record database of patients diagnosed with Covid-19. 
Descriptive research method with sampling technique using simple random sampling There were 100 samples consisting of 51 
men and 49 women, were taken in RS Tk.II Pelamonia Makassar on April 9th to 20th, 2021. For two days, focus of the study 
was obtained that the examination results of AST and ALT levels were from 100 samples showing that 74% of AST levels were 
normal and 26% were abnormal, while ALT levels were 72% normal and 28% abnormal. These results refer to the standard 
AST/SGOT for Men 10 - 37 U/l and Women 10 - 31 U/l, while for ALT/SGPT, for Men: 10 - 41 U/l and Women 10 - 31 U/l. 
The conclusion of the study showed that the normal results of AST levels were more than the abnormal values, as well as the 
normal values of ALT levels more than those that were not normal. It is recommended for further researcher to use more 
complete data and consider factor that can affect the examination results. 
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INTRODUCTION 
COVID-19 (Corona Virus Disease 2019) 
is an infectious disease caused by SARS-CoV-2, 
which is a species of coronavirus. Previously this 
virus was named 2019 Novel Coronavirus (2019-
nCoV) identified as the cause of the outbreak of 
a respiratory disease which was first detected in 
Wuhan, China and then in the end this disease 
resulted in a pandemic since 2020 (CDC, 2020). 
Common symptoms of COVID-19 patients are 
fever, dry cough, and difficulty breathing. For 
symptoms of sore throat, runny nose, or sneezing 
are less common. In patients who have low 
immunity or are susceptible, such as the elderly, 
this disease can lead to pneumonia and 
multiorgan failure. When a person is infected 
with the virus, symptoms will begin to appear in 
patients with a span of 5-6 days, but it can also 
take up to 14 days on average. (World Health 
Organization, 2020) 
This type of virus was initially detected in 
China, Hubei Province, precisely in Wuhan City 
on December 31, 2019 with cases of pneumonia 
symptoms in patients with no known cause 
(WHO, 2020). In Indonesia the COVID-19 
pandemic is confirmed to have spread to 
Indonesia starting on March 2, 2020, and finally 
the COVID-19 pandemic finally spread to all 
provinces in Indonesia on April 9, 2020 
(Wikipedia, 2020) 
According to data from WHO (2021) that 
globally, SARS-Cov-2 has spread to 222 
countries, a total of 82,579,768 people have been 
confirmed and 1,818,849 died due to infection 
with this virus. Then according to the COVID-19 
Handling Task Force (2020) data for Indonesia 
shows 76,5350 people have been confirmed 
positive, 63,1937 people have recovered, and 
22,734 people have died. 
Based on data from the official website of 
South Sulawesi Responding to Covid-19 (2021), 
it was reported that COVID-19 data as of January 
3, 2021 in South Sulawesi Province showed 
32,782 confirmed cases, 3,363 active cases, 
28,812 recovered (87.9% of confirmed), 607 died 
(1.9% of confirmed cases). % of confirmed), and 
11,339 people are suspected. While special data 
for Makassar City shows 12,828 total confirmed 
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cases, 10,367 recovered and 340 people died 
(City Government, 2021) 
 
The liver is the largest gland in the human 
body and is brownish red in color. The liver is the 
largest gland in the human body which weighs 
around 1,400 – 1,800 g in men and in women 
which is about 1,200-400 g, in general the liver 
covers 1/40 of the body weight. (Mashudi, 2011). 
in the body have various functions. The three 
basic functions of the liver are to form and 
secrete bile into the intestinal tract; plays a role 
in various metabolisms related to carbohydrates, 
lipids and proteins; filter the blood, get rid of 
bacteria and foreign objects that enter the blood 
(Maulina, 2018). The liver contains thousands of 
enzymes, some of which are also carried by the 
serum in very low amounts. They are distributed 
in plasma and interstitial fluid and have a 
characteristic half-life, usually in days. The 
increased activity of an enzyme in serum is 
thought to mainly reflect an increase in the rate 
at which the enzyme enters the serum from 
damaged liver cells. (Dan L. Longo and Anthony 
S Fauci, 2010).  
 Aminotransferase (transaminase) is a 
very specific parameter and is useful in assessing 
liver function in detecting acute hepatocellular 
disorders. This liver enzyme consists of aspartate 
aminotransferase (AST) and alanine 
aminotransferase (ALT). AST was found in order 
of decreasing concentration of liver, muscle, 
heart, skeletal muscle, kidney, brain, pancreas, 
lung, leukocytes, and erythrocytes. ALT is 
mainly found in the liver. In general, 
aminotransferase enzymes are normally only 
present in cells and very little in serum. If there 
is damage to the liver cell membrane resulting in 
an increase in cell permeability, these enzymes 
will be released and circulated in the blood 
circulation in greater concentrations (Dan L. 
Longo and Anthony S Fauci, 2010). 
COVID-19 patients with a severe 
infection phase will tend to have abnormalities in 
liver function tests. It may be that liver injury in 
COVID-19 is multifactorial, direct pathogenic 
effects of the virus, consumption of drugs that 
contain multiple side effects, systemic immune 
reactions and hypoxia which are potential causes 
of liver damage experienced by COVID-19 
patients. Some of the COVID-19 patients with 
impaired liver function also tend to have a worse 
prognosis. (Ali, 2020) 
Comorbid diseases such as acute inflammation 
and decreased organ function (heart, kidney, 
liver, and hematology as well as cardiovascular 
disease, chronic lung disease, diabetes, heart 
disease experienced by patients at the beginning 
of treatment can increase the severity of the 
disease and the risk of death due to COVID-19 
infection (Raden,2020) 
According to the study of Shweta et al 
(2020), it has been noted that death due to liver 
disease remains a significant association with 
COVID-19 among all comorbidities. In addition, 
the treatment regime involves drugs such as 
losartan, ACE inhibitors, angiotensin receptor 
blockers, Remdesivir, Chloroquine, 
Hydroxychlooquine, etc. can modulate 
comorbidity severity. With the conclusion that 
comorbidities can cause serious problems in the 
treatment process and can worsen the disease. 
Based on the results of a review by Tasha 
Salsabila et al (2020) that one of the mechanisms 
for increasing liver function is due to the 
hepatotoxic effect of several drugs used in the 
treatment of COVID-19 patients, such as 
chloroquine, macrolides, quinolones, and 
lopinavir/ritonavir. It was reported that there was 
an association between the use of 
lopinavir/ritonavir and ribavirin with the 
incidence of liver function abnormalities; 
lopinavir/ritonavir significantly increased AST, 
GGT levels and caused a slight increase in ALP 
levels 
According to Ali Nurshad's (2020) 
review, that the results of a recent study Hospitals 
reported elevated levels of AST (58%) and ALT 
(39%) in COVID-19 patients who had undergo 
treatment. Furthermore, AST levels increased by 
62% in patients in the Intensive Care Unit (ICU), 
and as much as 25% in non-ICU patients. 
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Another study reported that 76.3% had 
abnormalities in liver function tests and 21.5% 
had liver damage. This study shows that there is 
a relationship between elevated liver enzymes 
from the normal range that is considered 
abnormal and disease progression. If not treated 
properly, this enzyme causes severe liver 
damage. 
Based on the results of the study by Piano 
Salvatore, et al (2020) regarding Liver Function 
Test Abnormalities in predicting transfer to the 
ICU and death in COVID-19 patients, a study 
was conducted on 565 patients out of 615 who 
were hospitalized with confirmed COVID-19. 
And it was reported that as many as 329 patients 
(58%) had abnormal liver function tests. Among 
them for levels of AS T (44%) and ALT (32%).  
Based on the results of research by 
Darnindro Nikko, et al (2020) at Fatmawati 
Hospital there were 42 of the 191 patients who 
were treated had confirmed COVID-19 by PCR 
results. It was reported that there was an increase 
in AST enzymes as much as 71.4% and while 
ALT increased by 42.9% in patients. Of all 
patients, an increase in AST 1-2 times the normal 
value occurred in 14 patients (33.3%) and an 
AST increase> 2-fold above the upper normal 
limit (UNL) was found in 16 patients (38%). In 
contrast, the increase in ALT was similar for both 
groups, namely 1-2 times and 2 times above the 
normal value (21.4%). Mortality in COVID-19 
patients undergoing treatment in hospitals is still 
very high. One of the factors that influence the 
risk of poor prognosis in this disease is an 
increase in transaminase enzyme levels which 
are significantly associated with death. The 
higher the AST level, the higher the risk of death.  
Based on the description above, 
researchers are interested in conducting research 
on "Analysis of Examination Results for AST 
(Aspartate Aminotransferase) and ALT (Alanine 
Aminotransferase) levels in COVID-19 patients 
at Tk II Pelamonia Hospital Makassar". 
 
METHODS 
Type of Research, Location and Time 
The type of research used is laboratory 
observation, namely the analysis of the results of 
the examination of AST (Aspartate 
Aminotransferase) and ALT levels. (Aspartate 
Aminotransferase) in Covid-19 patients. 
Pelamonia Hospital Research Site, On 19 – April 
20, 2021. 
 
Population, Sample, Collection Technique 
The population in this study are COVID-
19 patients listed in the Home medical record 
Pelamonia Sick. The sample used in this study 
were COVID-19 patients who were tested for 
AST (Aspartate Aminotransferase) and ALT 
(Aspartate Aminotransferase) levels and listed in 
medical records in April 2020 – December 2020 
at Pelamonia Hospital. The sampling technique 
in this study is simple random sampling. With 
collected data on examinations of COVID-19 
patients from April 2020 – March 2021. The data 
used in this study were the results of examination 
of AST (Aspartate Aminotransferase) and ALT 
(Aspartate Aminotransferase) levels in Covid-19 
patients. 
 
Research Instruments and Materials 
The instruments that will be used in this 
research are, 3 ml syringe, non anticoagulant 
vacuum tube (red cap), tube rack micropipette 
tip, centrifuge, Cobas C-311 tool and personal 
protective equipment.(PPE), which consists of 
laboratory cats, masks, and handscoons. The 
materials that will be used in this research are 
Serum from Covid-19 Patients and 70% alcohol 
cotton. 
 
Research Instruments and Materials 
The instruments that will be used in this 
research are, 3 ml syringe, non anticoagulant 
vacuum tube (red cap), tube rack micropipette 
tip, centrifuge, Cobas C-311 tool and personal 
protective equipment. (PPE), which consists of 
laboratory coats, masks, and handscoons. The 
materials that will be used in this research are 
Serum from Covid-19 Patients and 70% alcohol 
cotton. 
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Research Work Procedure 
First, pre-analysis is carried out, namely: 
Turn on the tool: Turn on the instrument by 
pressing the power button on the right side of the 
tool, Turn on the computer and monitor control 
unit, Turn on the Cobas link, Log on to the 
monitor screen by entering the Operator ID and 
Password, the tool will automatically perform 
initialization and routine maintenance. After that 
is done the Calibration Procedure Select the 
Calibration Menu, Select Status, Select the test to 
be calibrated and select the calibration method, 
Do the same for all the tests you want to calibrate, 
Select Save, Select Start to start calibration. After 
performing the calibration process, continue with 
the Quality Control process, Select the Quality 
Control menu, select Status, select Select for the 
type of test to be controlled, Select Save (the 
selected parameter will be green), Place control 
on the specified disk sample, Select Start. Next is 
the Analytical Examination without barcodes, 
namely: Select Workplace, Select Test Selection, 
then select Routine(N), Enter the patient 
sequence number and then the sample position 
disk in the tool, Enter the patient sample ID (For 
samples with external dilution (manual), select 
predilution, For sample with internal dilution 
(automatically done by the tool), select the 
dilution factor from the sample volume / dilution 
column). Select the test you want to check, Select 
Save, Perform steps 1-6 for the other samples 
Select Start and then enter the first number of the 
patient sequence. Then check with barcode: 
Select System Overview, Select Sample 
Tracking, Place sample on disk, Place stop 
barcode after last sample, press sample scan, 
After standby, select Workplace, Select Test 
Selection, then select sample and parameters to 
be checked, Select Save, Select Start. Post-
Analytical Reading of Results: There are results 
in the form of sheets of paper that come out of the 
printer and monitor screen. Reporting Results 
Save the examination results obtained on the 
device and record the results in the album book 
Reference Value: AST/SGOT for Men 10 - 37 
U/l and Women 10 - 31 U/l, while for ALT/SGPT 




For the analysis of the results of the 
examination of AST (Aspartate 
Aminotransferase) and ALT (Aspartate 
Aminotransferase) levels in Covid-19 patients at 
the Tk II Pelamonia Hospital in Makassar, the 
results will be analyzed descriptively by first 
analyzing univariate to describe the frequency 
distribution of each variable, then bivariate 
analysis was carried out with Chi-square test 
(X2) to determine the relationship between each 
variable, then the results were discussed in a 
narrative manner. 
 
RESULTS AND DISCUSSION 
Based on table 4.1, it can be seen that 
from 100 Covid-19 patients, research subjects 
were divided into 4 age groups based on age, 
namely patients aged 6-24 years as many as 18 
people (18%), 25-43 years as many as 42 people 
(42% ), 44 - 62 years as many as 31 people 
(31%), and 63 - 81 years as many as 9 people 
(9%).  
Based on table 4.2, it can be seen that 
from 100 samples of Covid-19 patients, 51 
samples were obtained with male gender (51%) 
while 49 people (49%).  
Based on table 4.3, it can be seen that 
from 100 samples of Covid-19 patients, AST 
levels were obtained with normal values as many 
as 74 samples (74%) and abnormal as many as 26 
samples (26%). 
Based on table 4.4, it can be seen that 
from 100 samples of Covid-19 patients, 72 
samples (72%) of normal ALT levels were 
obtained and 28 samples (28%). 
In table 4.5 it can be seen that from 100 
samples of COVID-19 patients analyzed for the 
age group 6 – 24 years, the results of AST levels 
with normal values were 15 samples (15%), and 
3 samples were abnormal (3%). The 25-43 year 
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age group obtained AST levels with normal 
values in 30 samples (30%) and abnormal values 
in 12 samples (12%). In the 44-62 year age 
group, the results of AST levels were 22 samples 
(22%) normal and 9 samples (9%). In the age 
group 63 - 81 years, the results of AST levels 
were 7 samples (7%) normal and 2 samples (2%). 
In table 4.6, it can be seen that from 100 
samples of COVID-19 patients analyzed for the 
age group 6 – 24 years, ALT levels were obtained 
with normal values for 14 samples (14%), and 4 
samples (4%). In the 25-43 year age group, the 
results of ALT levels were 29 samples (29%) 
normal and 13 samples (13%). In the 44-62 year 
age group, the results of ALT levels were 21 
samples (21%) normal and 10 samples (10%). In 
the age group 63 - 81 years, the results of ALT 
levels were 8 samples (8%) normal and 1 sample 
(1%). 
In table 4.7 it can be seen that from 100 
samples of COVID-19 patients analyzed from 
the male sex variable, the results of AST levels 
were obtained with normal values for 35 samples 
(35%) and 16 samples (16%). From the female 
sex variable, the results of AST levels with 
normal values were 39 samples (39%) and 10 
samples (10%) were not normal. The relationship 
between the sex of Covid-19 patients and AST 
levels did not show significance, as evidenced by 
the p-value obtained ie 0.211 < 0.05. 
In table 4.8 it can be seen that from 100 
samples of COVID-19 patients analyzed from 
the male sex variable, the results of ALT levels 
were obtained with normal values as many as 31 
samples (31%) and abnormal as many as 20 
samples (20%). From the female gender variable, 
the results of ALT levels were obtained with a 
normal value of 41 samples (41%) and an 
abnormal value of 8 samples (8%) Relationship 
between patient gender Covid-19 with ALT 
levels showed significance as evidenced by the 
obtained p-value of 0.011 < 0.05. 
Aminotransferase enzymes or Also 
known as enzymes transaminase is an enzyme 
that catalyzes the transfer of an amino group 
reversibly between amino acids and alpha-keto . 
If a problem occurs or impaired liver function, it 
will there is a change in permeability cell 
membrane so that enzyme normal 
aminotransferases only is in the cell will enter 
into blood circulation, then it happens increase in 
enzyme levels aminotransferase in blood 
(Hartono, 2017) 
Two plasma transaminases, ALT and 
AST, are frequently used to demonstrate 
hepatocellular destruction. Both of these 
enzymes can be found in the hepatocyte cytosol 
and are released when cellular damage occurs. 
ALT is a more specific enzyme than AST 
because AST can also be found in cardiac 
muscle, skeletal muscle, and erythrocytes in 
addition to hepatocytes. (Walmsleyd, 2007) 
Liver function testing is commonly 
performed at the time of admission of COVID-
19 patients and is associated with systemic 
inflammation, organ dysfunction, and is an 
independent predictor of transfer to the ICU or 
death during hospitalization. Patients with 
abnormal liver function tests while being treated 
should be followed up carefully to prevent a 
possible worse outcome. (Piano,2020) 
Deaths that occur in COVID-19 patients 
are very much related to various factors including 
disorders of liver function. In other corona virus 
infections, the occurrence of liver dysfunction 
has been known to be very closely related to the 
cause of death. (Amalia, 2020) 
Based on the data obtained from 100 
samples, the results of research samples based on 
age, gender, AST and ALT levels in COVID-19 
patients were obtained. In the study sample, 100 
samples of patients were obtained consisting of 
age and gender variables. The age of the research 
subjects varied, ranging from 6 years to 81 years, 
so that 4 groups were obtained based on age, 
namely patients aged 6-24 years as many as 18 
people (18%), 25-43 years as many as 42 people 
(42%), 44 - 62 years as many as 31 people (31%), 
and 63 - 81 years as many as 9 people (9%). The 
determination of this age group is determined 
through manual calculation of the formula. 
Meanwhile, based on gender, the results were 51 
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men and 49 women. The lowest AST level was 9 
U/L and the highest AST level was 266 U/L 
while the lowest ALT level was 7 U/L. and the 
highest ALT level was 270 U/L. 
Based on these results, the most age 
sufferers from Covid-19 are patients aged 25 – 
43. This can happen because this age is a very 
productive and active age at work and is not 
much different from the age of 44 – 62 years who 
are still quite productive. in work. This is 
different when compared to other ages such as 
ages 6-24 years which include children and 
adolescents where the current learning process, 
both schools and universities, follows 
instructions from the local government, namely 
carrying out online learning as well as older ages, 
namely 63 – 81 years which is an age that tends 
to be no longer productive in work or active 
activities outside the home. 
As for gender, men are more likely to 
suffer from Covid-19, this is evidenced by 
differences in activities or activities and 
livelihoods where men are more frequent 
activities outside Women are more encouraged 
and are often at home to take care of the 
household 
It can be seen that from the 100 samples 
analyzed, the results of AST levels in COVID-19 
patients have been obtained with normal values 
as many as 74 samples (74%) and abnormal 
values as many as 26 samples (26%). And for 
ALT levels, the results of ALT levels in COVID-
19 patients obtained results with normal values 
of 72 samples (72%) and abnormal values of 28 
samples (28%). The results of this examination. 
Refer to value The normal used is AST/SGOT for 
Men 10 - 37 U/l and Women 10 - 31 U/l, while 
for ALT/SGPT are for Men: 10 - 41 U/l and 
Women 10-31 U/l. (Prameswari, 2014) 
Based on these results, it was stated that 
there were abnormal results of AST and ALT 
levels for some Covid-19 patients. That COVID-
19 continues to affect the catbolic and anabolic 
activities of the liver through hepatocyte injury, 
either caused by viral exposure or drug 
consumption and congenital disease, but most 
likely also caused by systemic inflammation due 
to complications of organ damage. 
In table 4.5, COVID-19 patients aged 6-
24 years have AST levels with normal values in 
15 samples (15%) and abnormal values in 3 
samples (3%). The 25-43 year age group 
obtained AST levels with normal values in 30 
samples (30%) and abnormal values in 12 
samples (12%). In the 44-62 year age group, the 
results of AST levels were 22 samples (22%) 
normal and 9 samples (9%). In the age group 63 
- 81 years, the results of AST levels were 7 
samples (7%) normal and 2 samples (2%). While 
in table 4.6 for ALT levels for the age group 6 – 
24 years 
 The results obtained ALT levels with 
normal values as many as 14 samples (14%), and 
abnormal as many as 4 samples (4%). In the 25-
43 year age group, the results of ALT levels were 
29 samples (29%) normal and 13 samples (13%). 
In the 44-62 year age group, the results of ALT 
levels were 21 samples (21%) normal and 10 
samples (10%). The age group 63 - 81 years 
obtained ALT levels with normal values as many 
as 8 samples (8%) and 1 sample abnormal (1%) 
Everyone who has reached old age has 
the potential to experience health problems, this 
is because the human immune system will 
decline with age, which makes it difficult to fight 
disease. In old age the lung lining will begin to 
become less elastic, this is quite deadly and 
dangerous for people who have entered old age 
due to inflammation caused by the Covid-19 
disease, resulting in damage to vital organs such 
as the liver. However, a person's immune factor 
is still very influential. (CDC,2020) 
In table 4.7, it can be seen that patients 
with male sex have AST levels with normal 
values as many as 35 samples and abnormal as 
many as 16 samples. As for the female gender, 
the results of AST levels with normal values were 
39 samples and not normal as many as 10 
samples. However, based on these results, the 
relationship between the sex of Covid-19 patients 
and AST levels did not show any significance. 
male gender has ALT levels with normal values 
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were 31 samples and 20 samples were not 
normal. As for the female gender, there were 41 
samples of normal ALT levels and 8 samples that 
were abnormal. The relationship between the sex 
of Covid-19 patients and ALT levels showed 
significance, as evidenced by the results 
obtained. 
Based on these results, the increase in 
ALT levels was more common in males than 
females. This is usually the case caused by 
different habits and life activities where men tend 
to have the habit of consuming cigarettes and 
alcohol where there is a depletion of 
hepatoprotective glutathione. It is evident that 
gender can be a major risk factor for mortality in 
COVID-19 patients, and it is evident that men 
have a higher frequency of death than women. 
This is caused by some basic distinctive 
differences of the immune system, lifestyle 
activities, and cigarette consumption. 
(Raden,2020) 
The results of this study are in line with 
research conducted by Darnindro Nikko, et al 
(2020) at Fatmawati Hospital on COVID-19 
patients confirmed by PCR results. It was 
reported that there was an increase in AST 
enzyme as much as 33.3% and while ALT 
increased by 42.9% in patients. One of the factors 
that influence the risk of poor prognosis in this 
disease is an increase in transaminase enzyme 
levels which are significantly associated with 
mortality rates. 
However, the results of this study are not 
in line with the review conducted by Ali Nurshad 
(2020), recently at the hospital reported increased 
levels of AST (58%) and ALT (39%) in COVID-
19 patients undergoing treatment. Furthermore, 
AST levels increased by 62% in patients in the 
Intensive Care Unit (ICU), and as much as 25% 
in non-ICU patients. Another study reported that 
76.3% had abnormalities on liver function tests 
and 21.5% had liver damage. This study shows 
that there is a relationship between elevated liver 
enzymes from the normal range which is 
considered abnormal and the development of 
liver enzymes. 
This is similar to the results of the study 
by Piano Salvatore, et al (2020) regarding Liver 
Function Test Abnormalities in COVID-19 
patients, a study was conducted on 565 patients 
out of 615 who were hospitalized with confirmed 
COVID-19. And it was reported that as many as 
329 patients (58%) had abnormal liver function 
tests including ICU patients who died. Among 
them for levels of AST (44%) and ALT (32%). 
Based on the results of several related 
research can be concluded that the increase in 
aminotransferase enzymes or abnormal levels of 
AST and ALT enzymes is also very dependent on 
the level of infection stage of the virus or the 
severity of the patient during exposure to the 
virus. in the initial infection include fever, dry 
cough, shortness of breath and some experience 
condition that worsens resulting in respiratory 
system problems. This is certainly different from 
the patient end stage which has clinical 
manifestations in the form of syndrome 
extrapulmonary systemic hyperinflammation 
and at this stage, several signs of high systemic 
inflammation have emerged that lead to a 
decrease in helper T cells, resulting in 
inflammatory cytokines and biomarkers such as 
IL-2, IL-6, IL-7, G-CSF, macrophage 
inflammatory protein 1- a, TNF-a, C-RP, ferritin, 
and D-dimer were significantly increased in 
these patients and strongly affected liver 
function. 
Elevated levels of transaminase enzymes 
in COVID-19 patients may be due to direct viral 
injury or other extrahepatic conditions. This can 
specifically explain the increase in AST levels. 
These elevated levels suggest that COVID-19 
affects the catbolic and anabolic activities of the 
liver through hepatocyte injury. Hepatocyte 
dysfunction can cause a poor response to 
infection because there is a decrease in the 
synthesis of proteins that are important in 
fighting infection. This leads to suppressed 
immune status which makes the patient 
susceptible to secondary bacterial infections. 
Secondary bacterial infection can increase 
mortality and disease severity in 19 COVID-19 
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patients (Boregowda, 2020). But also need to 
know is this enzyme increase caused by liver 
dysfunction directly correlated with viral 
exposure in COVID-19 patients. Extrahepatic 
sources such as muscle injury can also cause an 
increase in AST and ALT. (Therefore, it is very 
important to differentiate AST and ALT 
elevation due to muscle injury from liver injury 
due to COVID 19 (Boregowda, 2020). 
Clinical implications of ALT 
examination according to guidelines The clinical 
interpretation issued by the Ministry of Health is 
that it occurs in hepatocellular disease, active 
cirrhosis, biliary obstruction and hepatitis, 
obesity, acute lymphoblastic leukemia (ALL), 
consumption of drugs that increase serum 
transaminases such as Acetaminophen, Co-
amoxylate, HMGCoA reductase inhibitors, INH, 
Nonsteroidal anti-inflammatory drugs, 
Phenytoin, and Valproate. The elevation value 
corresponding to this is an increase of two times 
the normal limit. (Ministry of Health RI, 2011) 
Abnormalities in liver function tests in 
patients with COVID-19 can be caused by 
several mechanisms or various factors. SARS-
CoV-2 binds to target cells via angiotensin-
converting enzyme 2, which occurs abundantly 
in liver and epithelial cells biliary. Thus, the liver 
is a potential target for detecting infections and 
abnormalities in liver function tests may be due 
to a direct viral induced cytopathic 
effect.(Piano). Although some postmortem 
histopathological studies have demonstrated the 
presence of the viral genome in the liver, but 
other studies have not confirmed these results. 
However, impaired immunity from the resulting 
inflammatory response is a potential concurrent 
or alternative mechanism by which this disease 
can lead to liver damage. (Piano,2020) 
Research shows that patients with 
abnormal liver function tests have more severe 
systemic inflammation characterized by elevated 




Based on the research results, For Covid-
19 patients it is recommended that you stay check 
the levels of AST and ALT in handling because 
very useful in determining the etiology and 
assess disease prognosis and evaluate treatment, 
Share 
The public is strongly encouraged to 
follow the directions of the government local, 
namely by complying with implementation of the 
3 M . Health Protocol or 5 M in daily activities 
outside the home in order to reduce risk of 
exposure to Covid-19, For researchers then it is 
recommended to do research using data more and 
more complete as well use more data analysis 
complex related to the factors that affect the 
results of the examination. 
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6 – 24 18 18  
    
25 – 43 42 42  
    
44 – 62 31 31  
    
63 - 81 9 9  
    
Total 100 100  
 
Source : Secondary Data, 2020 
 
 
Table 4.2.Distribution of the frequency of Covid-19 patients with sex variables 
 
Gender N % 
   
Man 51 51 
   
Woman 49 49 
   
Total 100 100 
 
Source : Secondary Data, 2020 
 
 
Table 4.3. Distribution of the frequency of Covid-19 patients based on the results of AST levels. 
 
AST Level N % 
   
Normal 74 74 
   
Abnormal 26 26 
   
Total 100 100 
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Table 4.4.Distribution of the frequency of Covid-19 patients based on the results of ALT levels. 
 
ALT Level N % 
   
Normal 72 72 
   
Abnormal 28 28 
   
Total 100 100 
 
Source : Secondary Data, 2020 
 
Table 4.5.Distribution of the frequency of AST levels based on the variable Age 
 
Age 
 AST Level   





     
 N % n %  
      
6 - 24 15 15 3 3  
      
25 - 43 30 30 12 12  
      
44 - 62 22 22 9 9  
      
63 - 81 7 7 2 2  
 
Source : Secondary Data, 2020 
 
Table 4.6.Frequency distribution of ALT levels based on the variable age  
 
Age 
 ALT Level   





     
 N % n %  
      
6 - 24 14 14 4 4  
      
25 - 43 29 29 13 13  
      
44 - 62 21 21 10 10  
      
63 - 81 8 8 1 1  
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Source : Secondary Data, 2020 
 
Table 4.7.Frequency distribution of AST levels by Gender 
 
                                          AST Level 
 
Gender Normal Abnormal p value  
       
 n % N %   
       
Man 35 35 16 16   
     
0,211 
 




Source : Secondary Data, 2020 
 
 
Table 4.8.Frequency distribution of ALT levels by Gender 
 
                                          ALT Level 
 
Gender Normal Abnormal p value  
       
 n % N %   
       
Man 35 35 16 16   
     
0,011 
 




Source : Secondary Data, 2020 
 
 
 
 
 
 
 
